NEVVI Medicare utilization intelligence
or

← back

Provider profile

KANE, KELLY MD

Dermatology · NPI 1497776579 · SOMERS POINT, NJ

1
Groups
31
Codes · 2024
47,433
Disclosed services

KANE, KELLY is a Dermatology in SOMERS POINT, NJ, a member of 1 medical group, who billed 31 distinct codes to Medicare Part B in 2024.

Groups: KANE MEDICAL LLC (SOMERS POINT, NJ)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

47,433
disclosed services
31
codes billed to Medicare Part B
Prior year · CY2023 41,872 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
G6001 Ultrasonic guidance for placement of radiation therapy fields
77280 Obtaining data needed to develop the optimal radiation treatment, 1 treatment area
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
77401 Superficial and/or low voltage radiation treatment delivery
17003 Destruction of precancer skin growth, 2-14 growths
11102 Biopsy of related skin growth, first growth
17000 Destruction of precancer skin growth, 1 growth
17110 Destruction of skin growth, 1-14 growths
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
11103 Biopsy of related skin growth, each additional growth
96574 Application of light with debridement to destroy precancer skin growth
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
77300 Calculation of radiation therapy dose
77336 Continuing radiation therapy consultation per week
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
77261 Simple radiation therapy planning
77332 Design and construction of simple radiation treatment device
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
69100 Biopsy of ear
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
77334 Design and construction of complex radiation treatment device
11900 Injection into skin growth, 1-7 growths
77333 Design and construction of intermediate radiation treatment device
11300 Shaving of skin growth of body, arms, or legs, 0.5 cm or less
11401 Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm
77262 Intermediate radiation therapy planning
77285 Obtaining data needed to develop the optimal radiation treatment, 2 treatment areas
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.